Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $213,750 - $279,750
-75,000 Closed
0 $0
Q2 2021

Sep 21, 2023

SELL
$4.26 - $6.5 $160,602 - $245,050
-37,700 Reduced 33.45%
75,000 $328,000
Q2 2021

Aug 20, 2021

SELL
$4.26 - $6.5 $31.6 Million - $48.3 Million
-7,425,000 Reduced 99.0%
75,000 $329,000
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $31.5 Million - $48 Million
7,387,300 Added 6554.84%
7,500,000 $329,000
Q1 2021

Sep 21, 2023

BUY
$5.03 - $8.8 $377,250 - $660,000
75,000 Added 198.94%
112,700 $699,000
Q1 2021

May 14, 2021

BUY
$5.03 - $8.8 $377,250 - $660,000
75,000 Added 198.94%
112,700 $700,000
Q4 2020

Sep 21, 2023

BUY
$4.04 - $5.31 $152,308 - $200,186
37,700 New
37,700 $184,000
Q2 2020

Nov 02, 2020

BUY
$4.78 - $8.26 $180,206 - $311,402
37,700 New
37,700 $261,000
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $697,402 - $1.21 Million
-145,900 Closed
0 $0
Q1 2020

Nov 24, 2020

BUY
$4.0 - $21.53 $583,600 - $3.14 Million
145,900 New
145,900 $1.98 Million
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $547,600 - $2.95 Million
-136,900 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$13.94 - $24.12 $1.27 Million - $2.19 Million
90,900 Added 197.61%
136,900 $2.94 Million
Q3 2019

Nov 13, 2019

BUY
$13.89 - $23.16 $347,250 - $579,000
25,000 Added 119.05%
46,000 $697,000
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $3.61 Million - $4.55 Million
-221,800 Reduced 91.35%
21,000 $407,000
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $1.55 Million - $2.75 Million
-123,200 Reduced 33.66%
242,800 $5.04 Million
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $2.57 Million - $4.76 Million
-207,200 Reduced 36.15%
366,000 $4.98 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $1.4 Million - $9.33 Million
573,200 New
573,200 $9.33 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.